Rationale and design of the Mechanistic Substudy of the Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE): Effects of pitavastatin on coronary artery disease and inflammatory biomarkers

BACKGROUND: People with HIV (PWH) have increased cardiovascular events, inflammation, and high-risk coronary atherosclerosis. Statin therapy has been shown to lower the risk of cardiovascular disease (CVD) in the general population, but whether this results from reductions in coronary atherosclerosi...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Am Heart J
Asıl Yazarlar: Hoffmann, Udo, Lu, Michael T., Olalere, Devvora, Adami, Elizabeth C., Osborne, Michael T., Ivanov, Alex, Sukumar Aluru, John, Lee, Saeyun, Arifovic, Nadja, Turner Overton, Edgar, Fichtenbaum, Carl J., Aberg, Judith A., Alston-Smith, Beverly, Klingman, Karin L., Waclawiw, Myron, Burdo, Tricia H., Williams, Kenneth C., Zanni, Markella V., Desvigne-Nickens, Patrice, Cooper-Arnold, Katharine, Fitch, Kathleen V., Ribaudo, Heather, Douglas, Pamela S., Grinspoon, Steven K.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2019
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6596304/
https://ncbi.nlm.nih.gov/pubmed/30928823
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ahj.2019.02.011
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller